104 related articles for article (PubMed ID: 17079872)
1. Low-dose radiation response of the p21WAF1/CIP1 gene promoter transduced by adeno-associated virus vector.
Nenoi M; Daino K; Ichimura S; Takahash S; Akuta T
Exp Mol Med; 2006 Oct; 38(5):553-64. PubMed ID: 17079872
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines.
Parker LP; Wolf JK; Price JE
Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764
[TBL] [Abstract][Full Text] [Related]
3. [Construction, packaging and titration of recombinant adeno-associated virus vectors contaning antitumor genes].
Zhang Y; Leng X; Peng J; He X; Lu J; Weng S; Wang S; Du J
Zhonghua Yi Xue Za Zhi; 2002 Apr; 82(8):564-7. PubMed ID: 12133507
[TBL] [Abstract][Full Text] [Related]
4. Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoter.
Mimuro J; Muramatsu S; Hakamada Y; Mori K; Kikuchi J; Urabe M; Madoiwa S; Ozawa K; Sakata Y
Gene Ther; 2001 Nov; 8(22):1690-7. PubMed ID: 11892836
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia- and radiation-activated Cre/loxP 'molecular switch' vectors for gene therapy of cancer.
Greco O; Joiner MC; Doleh A; Powell AD; Hillman GG; Scott SD
Gene Ther; 2006 Feb; 13(3):206-15. PubMed ID: 16307003
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
Park US; Park SK; Lee YI; Park JG; Lee YI
Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
[TBL] [Abstract][Full Text] [Related]
7. Light-activated gene transduction enhances adeno-associated virus vector-mediated gene expression in human articular chondrocytes.
Ulrich-Vinther M; Maloney MD; Goater JJ; Søballe K; Goldring MB; O'Keefe RJ; Schwarz EM
Arthritis Rheum; 2002 Aug; 46(8):2095-104. PubMed ID: 12209514
[TBL] [Abstract][Full Text] [Related]
8. Gamma-rays enhance rAAV-mediated transgene expression and cytocidal effect of AAV-HSVtk/ganciclovir on cancer cells.
Kanazawa T; Urabe M; Mizukami H; Okada T; Kume A; Nishino H; Monahan J; Kitamura K; Ichimura K; Ozawa K
Cancer Gene Ther; 2001 Feb; 8(2):99-106. PubMed ID: 11263531
[TBL] [Abstract][Full Text] [Related]
9. Development of synthetic promoters for radiation-mediated gene therapy.
Marples B; Scott SD; Hendry JH; Embleton MJ; Lashford LS; Margison GP
Gene Ther; 2000 Mar; 7(6):511-7. PubMed ID: 10757025
[TBL] [Abstract][Full Text] [Related]
10. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
Cheng J; Leng X; Peng J
Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
[TBL] [Abstract][Full Text] [Related]
11. The plant alkaloid cryptolepine induces p21WAF1/CIP1 and cell cycle arrest in a human osteosarcoma cell line.
Matsui TA; Sowa Y; Murata H; Takagi K; Nakanishi R; Aoki S; Yoshikawa M; Kobayashi M; Sakabe T; Kubo T; Sakai T
Int J Oncol; 2007 Oct; 31(4):915-22. PubMed ID: 17786325
[TBL] [Abstract][Full Text] [Related]
12. Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.
Rohr UP; Wulf MA; Stahn S; Heyd F; Steidl U; Fenk R; Opalka B; Pitschke G; Prisack HB; Bojar H; Haas R; Kronenwett R
Cancer Gene Ther; 2003 Dec; 10(12):898-906. PubMed ID: 14712316
[TBL] [Abstract][Full Text] [Related]
13. Additional gene therapy with rAAV-wt-p53 enhanced the efficacy of cisplatin in human bladder cancer cells.
Ruifa H; Liwei L; Binxin L; Ximing L
Urol Int; 2006; 77(4):355-61. PubMed ID: 17135787
[TBL] [Abstract][Full Text] [Related]
14. Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity.
Robson T; Worthington J; McKeown SR; Hirst DG
Technol Cancer Res Treat; 2005 Aug; 4(4):343-61. PubMed ID: 16029055
[TBL] [Abstract][Full Text] [Related]
15. Ionizing radiation: a genetic switch for cancer therapy.
Mezhir JJ; Smith KD; Posner MC; Senzer N; Yamini B; Kufe DW; Weichselbaum RR
Cancer Gene Ther; 2006 Jan; 13(1):1-6. PubMed ID: 16082378
[TBL] [Abstract][Full Text] [Related]
16. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor.
Chao CH; Chen CM; Cheng PL; Shih JW; Tsou AP; Lee YH
Cancer Res; 2006 Jul; 66(13):6579-88. PubMed ID: 16818630
[TBL] [Abstract][Full Text] [Related]
17. Empirical advantages of adeno associated viral vectors in vivo gene therapy for arthritis.
Goater J; Müller R; Kollias G; Firestein GS; Sanz I; O'Keefe RJ; Schwarz EM
J Rheumatol; 2000 Apr; 27(4):983-9. PubMed ID: 10782827
[TBL] [Abstract][Full Text] [Related]
18. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM
Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668
[TBL] [Abstract][Full Text] [Related]
19. Use of the radiation-inducible WAF1 promoter to drive iNOS gene therapy as a novel anti-cancer treatment.
Worthington J; McCarthy HO; Barrett E; Adams C; Robson T; Hirst DG
J Gene Med; 2004 Jun; 6(6):673-80. PubMed ID: 15170738
[TBL] [Abstract][Full Text] [Related]
20. Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells.
Chung I; Schwartz PE; Crystal RG; Pizzorno G; Leavitt J; Deisseroth AB
Cancer Gene Ther; 1999; 6(2):99-106. PubMed ID: 10195877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
